Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
05/1999
05/06/1999EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines
05/06/1999EP0912595A1 Hodgkin's disease associated molecules and uses thereof
05/06/1999EP0912592A1 Phosphotriester oligonucleotides, amidites and method of preparation
05/06/1999EP0912239A1 Method for providing dense particle compositions for use in transdermal particle delivery
05/06/1999DE19747718A1 Use of gene therapy
05/06/1999CA2308511A1 Use of transfected or transduced mammalian cells for treating bone pathologies
05/06/1999CA2307953A1 Gene therapy for stimulation of angiogenesis
05/06/1999CA2306733A1 Compositions and methods for delivery of genetic material
05/06/1999CA2252999A1 Novel rncs
05/05/1999CN1216064A Synthetic HIV genes
05/05/1999CN1215994A Rnase L activators and antisense oligonucleotides effective to treat RSV infections
05/05/1999CN1215986A Methods for preparing gas-filled liposomes
04/1999
04/30/1999CA2249056A1 Lacc
04/30/1999CA2248996A1 Novel ornithine carbamoyltransferase
04/29/1999WO1999020774A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
04/29/1999WO1999020766A2 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
04/29/1999WO1999020757A2 Alpha-7 nicotinic receptor
04/29/1999WO1999020755A2 Novel cytokine receptors
04/29/1999WO1999020747A2 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
04/29/1999WO1999020742A2 A packaging cell line producing siv-pseudotyped mlv
04/29/1999WO1999020644A1 Secreted proteins and polynucleotides encoding them
04/29/1999WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response
04/29/1999WO1999020641A1 New triplex forming oligonucleotides and their use in anti-hbv
04/29/1999WO1999020311A1 METHODS FOR CANCER IMMUNOTHERAPY USING RETROVIRAL VECTORS EXPRESSING η INTERFERON
04/29/1999WO1999020308A1 A method for inhibiting metastasis and tumor cell growth by clinically modulating tumor expression of fas ligand
04/29/1999WO1999020307A1 NOVEL pheS (BETA)
04/29/1999WO1999020302A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
04/29/1999WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
04/29/1999WO1999020297A1 Prevention and treatment of adhesion formation
04/29/1999WO1999020108A1 Human papillomavirus vectors for the episomal transduction of host cells and method of making same
04/29/1999WO1999006551A3 5' ESTs FOR SECRETED PROTEINS IDENTIFIED FROM BRAIN TISSUES
04/29/1999WO1999006026A9 Stable particulate complexes with neutral or negative global charge of lamellar structure
04/29/1999WO1999004825A9 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
04/29/1999WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders
04/29/1999WO1999004636A9 Evaluation of, delivery of, and use of agents to treat heart disorders
04/29/1999WO1998048027A9 Materials and methods for treatment of retinal diseases
04/29/1999WO1998046274A3 Cationic polymers for nucleic acid transfection
04/29/1999WO1998044134A3 Bacterial plasmids
04/29/1999DE19756864C1 Production of neuronal or glial progenitor cells
04/29/1999CA2308013A1 Human checkpoint kinase, hcds1, compositions and methods
04/29/1999CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
04/29/1999CA2307012A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
04/29/1999CA2306799A1 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
04/29/1999CA2306796A1 Novel modified msp-1 nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
04/29/1999CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response
04/29/1999CA2306457A1 Secreted proteins and polynucleotides encoding them
04/29/1999CA2306251A1 Alpha-7 nicotinic receptor
04/28/1999EP0911413A2 Minimal adenovirus-based gene therapy vector
04/28/1999EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family
04/28/1999EP0911409A2 Deformylase
04/28/1999EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC
04/28/1999EP0911406A2 Histidine kinase from Staphylococcus aureus
04/28/1999EP0911405A2 Gapdh
04/28/1999EP0911403A2 MurB gene from Streptococcus pneumoniae
04/28/1999EP0911402A2 PyrR homolog from Staphylococcus aureus
04/28/1999EP0911399A2 A kringle-related clone, HTHBZ47
04/28/1999EP0910669A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof
04/28/1999EP0910656A1 Virus-like particles useful as a vector for delivering nucleic acid
04/28/1999EP0910654A1 Enzyme combinations for destroying proliferative cells
04/28/1999EP0910653A2 A cytoplasmic gene expression system which utilizes a prokaryotic rna polymerase autogene
04/28/1999EP0910646A1 Brain glycogen phosphorylase cancer antigen
04/28/1999EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha
04/28/1999EP0910644A1 Retinoid metabolizing protein
04/28/1999EP0910641A1 Neural cell adhesion molecule splicing variants
04/28/1999EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG
04/28/1999EP0910638A2 Polynucleotide encoding secreted proteins
04/28/1999EP0910634A2 ANTISENSE INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEgF/VPF) EXPRESSION
04/28/1999EP0910632A2 Presentation of antigen, introduced into the cells by stimulation of macropinocytosis
04/28/1999EP0910628A1 Inactivation resistant factor viii
04/28/1999EP0910578A2 Recombinant expression of proteins from secretory cell lines
04/28/1999EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis
04/28/1999EP0910569A1 Extracellular/epidermal growth factor-like protein
04/28/1999EP0910409A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
04/28/1999EP0910387A1 Apoptosis associated protein bbk
04/28/1999EP0910343A1 Emulsion formulations for hydrophilic active agents
04/28/1999EP0910246A1 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
04/28/1999EP0775150B1 Endotoxin reduction or removal process
04/28/1999CN1215058A Novel trichain formed eliyonucleotide structure and application to anti-virus of hepatitis B
04/28/1999CA2248274A1 Novel dbpa
04/28/1999CA2248270A1 Novel dbpb
04/27/1999US5898031 Oligoribonucleotides for cleaving RNA
04/27/1999CA2248119A1 Novel apt
04/27/1999CA2248116A1 Novel muty
04/24/1999CA2248170A1 A clone hwhhj20
04/23/1999CA2245997A1 Novel compounds
04/22/1999WO1999019732A1 Methods and compositions for detecting hepatitis e virus
04/22/1999WO1999019500A1 Complex of biotinylated viral vector and ligand for targeted gene delivery
04/22/1999WO1999019496A1 Inhibition of human immunodeficiency virus (hiv-1) replication
04/22/1999WO1999019485A1 THYMOSIN β15 PROMOTER AND USE THEREOF
04/22/1999WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor
04/22/1999WO1999019481A2 Mammalian genes involved in viral infection and tumor suppression
04/22/1999WO1999019479A1 Murine model for human carcinoma
04/22/1999WO1999019478A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
04/22/1999WO1999019473A1 Transgenic animal models for cardiac hypertrophy and uses thereof
04/22/1999WO1999019471A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function
04/22/1999WO1999019466A2 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
04/22/1999WO1999019359A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
04/22/1999WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
04/22/1999WO1999019352A2 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
04/22/1999WO1999019349A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
1 ... 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 ... 870